Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer
29 September 2010 | By Citigate Dewe Rogerson
Creabilis SA, today announced the appointment of Eliot Forster as its new Chief Executive Officer...
List view / Grid view
News
Results of Zibotentan Phase III trial in castration resistant prostate cancer
27 September 2010 | By AstraZeneca
AstraZeneca announced that a study evaluating zibotentan for the treatment of men with metastatic CRPC did not show improvement in the primary endpoint of overall survival...
New version of Copley Scientific’s inhaler testing software adds automatic data import from Waters Empower
27 September 2010 | By Kapler Communications
Copley Scientific has introduced a new version of its widely used CITDAS...
BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
24 September 2010 | By AstraZeneca
AstraZeneca announced that the CHMP issued a positive opinion on the marketing authorisation...
Synexus puts Medical Affairs at the top of its agenda with new Chief Medical Officer
23 September 2010 | By Synexus
Synexus has appointed Dr Glynis Neagle as Chief Medical Officer...
Tecan’s Freedom EVO® automates tropical disease research
23 September 2010 | By kdm communications limited
The Clinical Pharmacology Department has chosen Tecan’s Freedom EVO® platform to automate research into the pharmacology of anti-malarial and anti-influenza drugs...
Shire plc becomes OBN’s first Corporate Patron
23 September 2010 | By Citigate Dewe Rogerson
OBN, announced today that global specialty pharmaceutical company Shire has become the network’s first Corporate Patron...
bioMérieux Awarded NHSBT Contract for Bacterial Screening of Platelets
20 September 2010 | By kdm communications limited
bioMérieux, was chosen by National Health Service Blood and Transplant (NHSBT) for bacterial screening of platelets in England and North Wales...
Creabilis Appoints George F. Horner III as its Chairman
15 September 2010 | By Citigate Dewe Rogerson on behalf of Creabilis SA
Creabilis SA, today announced the appointment of George F. Horner III as its Chairman...
Sigma® Life Science to Supply Oligonucleotides to Research Councils UK
14 September 2010 | By kdm communications limited
Sigma® Life Science, signed a 3 year contract with RCUK Shared Services Centre to be a prefered supplier for synthetic oligonucleotides...
Rexahn Pharmaceuticals Announces the Appointment of Peter Brandt and Richard Kivel to Board of Directors
13 September 2010 | By Rexahn Pharmaceuticals
Rexahn Pharmaceuticals, Inc. announced the appointment of Peter Brandt and Richard Kivel to the company's board of directors...
AstraZeneca, GlaxoSmithKline, Pfizer & Roche discuss the future of the pharma industry
10 September 2010 | By NG Online News
Fears of layoffs at pharmaceutical companies are once again dominating the news, but could there be a less painful way to save money?
Brecon Celebrates 30th Anniversary with Strong Performance
7 September 2010 | By AD Communications
Brecon Pharmaceuticals has followed its strong 2009 performance with a record performance in 2010...
Government Applies Pressure for Continuous Temperature Monitoring
7 September 2010 | By Public Ltd
The Government’s Medicines & Healthcare Products Regulatory Agency, is currently spearheading a drive for continuous temperature monitoring right across the ‘cold chain’...
New market leader for clinical cytogenetics laboratory services
6 September 2010 | By kdm communications limited
Sure Laboratories is an independent clinical cytogenetics service laboratory providing dedicated microarray-based comparative genomic hybridisation screening...
